Abstract | BACKGROUND: Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for the treatment of diabetic wound healing. The present study aimed to investigate the effect of exosomes derived from MSCs pretreated with pioglitazone (PGZ-Exos) on diabetic wound healing. RESULTS: We isolated PGZ-Exos from the supernatants of pioglitazone-treated BMSCs and found that PGZ-Exos significantly promote the cell viability and proliferation of Human Umbilical Vein Vascular Endothelial Cells (HUVECs) injured by high glucose (HG). PGZ-Exos enhanced the biological functions of HUVECs, including migration, tube formation, wound repair and VEGF expression in vitro. In addition, PGZ-Exos promoted the protein expression of p-AKT, p-PI3K and p-eNOS and suppressed that of PTEN. LY294002 inhibited the biological function of HUVECs through inhibition of the PI3K/AKT/eNOS pathway. In vivo modeling in diabetic rat wounds showed that pioglitazone pretreatment enhanced the therapeutic efficacy of MSCs-derived exosomes and accelerated diabetic wound healing via enhanced angiogenesis. In addition, PGZ-Exos promoted collagen deposition, ECM remodeling and VEGF and CD31 expression, indicating adequate angiogenesis in diabetic wound healing. CONCLUSIONS: PGZ-Exos accelerated diabetic wound healing by promoting the angiogenic function of HUVECs through activation of the PI3K/AKT/eNOS pathway. This offers a promising novel cell-free therapy for treating diabetic wound healing.
|
Authors | Yiqiang Hu, Ranyang Tao, Lang Chen, Yuan Xiong, Hang Xue, Liangcong Hu, Chenchen Yan, Xudong Xie, Ze Lin, Adriana C Panayi, Bobin Mi, Guohui Liu |
Journal | Journal of nanobiotechnology
(J Nanobiotechnology)
Vol. 19
Issue 1
Pg. 150
(May 21 2021)
ISSN: 1477-3155 [Electronic] England |
PMID | 34020670
(Publication Type: Journal Article)
|
Chemical References |
- Angiogenesis Inducing Agents
- Collagen
- Pioglitazone
|
Topics |
- Angiogenesis Inducing Agents
(pharmacology)
- Animals
- Cell Movement
(drug effects)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Collagen
(metabolism)
- Diabetes Mellitus
(metabolism)
- Diabetes Mellitus, Experimental
- Exosomes
(metabolism)
- Human Umbilical Vein Endothelial Cells
(drug effects)
- Humans
- Male
- Mesenchymal Stem Cells
(metabolism)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Pioglitazone
(metabolism, pharmacology)
- Rats
- Rats, Sprague-Dawley
- Skin
(drug effects)
- Wound Healing
(drug effects)
|